Chemotherapy Benefits End at Age 70 in Colorectal Cancer. (IMAGE)

Korea University College of Medicine

Chemotherapy Benefits End at Age 70 in Colorectal Cancer.

Caption

A nationwide Korean study of 8,500 patients found oxaliplatin-based chemotherapy boosts survival in stage III colorectal cancer only for those aged 70 or younger. In patients over 70, the drug showed no survival benefit and caused higher treatment dropout due to side effects. Stage II patients saw no benefit at any age.

Credit

Prof. Jun Woo Bong and Korea University College of Medicine

Usage Restrictions

Cannot be reused without permission

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.